Page 97 - OR-1-3

291. Levesque S, Bauer DE. CRISPR-based therapeutic genome 2025;12:2500632.
editing for inherited blood disorders. Nat Rev Drug Discov. doi: 10.1002/advs.202500632
2025.
293. Saito A, Ooki A, Nakamura T, et al. Targeted reversion of
doi: 10.1038/s41573-025-01236-y induced pluripotent stem cells from patients with human
292. Xu R, Zhu S, Zhang W, et al. A dual approach with cleidocranial dysplasia improves bone regeneration in a rat
organoid and CRISPR screening reveals ERCC6 as a calvarial bone defect model. Stem Cell Res Ther. 2018;9:12.
determinant of cisplatin resistance in osteosarcoma. Adv Sci. doi: 10.1186/s13287-017-0754-4

Volume 1 Issue 3 (2025) 39 doi: 10.36922/OR025280024